国邦医药
(605507)
| 流通市值：133.67亿 | | | 总市值：133.67亿 |
| 流通股本：5.59亿 | | | 总股本：5.59亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,511,599,155.4 | 1,460,007,401.61 | 1,312,110,423.39 | 1,558,068,520.04 |
| 交易性金融资产 | 1,253,626,666.81 | 1,242,959,821.37 | 896,343,049.03 | 693,885,850.78 |
| 应收票据及应收账款 | 1,016,832,203.05 | 859,327,348.29 | 874,649,776.33 | 904,916,262.57 |
| 应收账款 | 1,016,832,203.05 | 859,327,348.29 | 874,649,776.33 | 904,916,262.57 |
| 应收款项融资 | 586,848,039.57 | 535,130,099.7 | 549,619,057.46 | 600,058,634.95 |
| 预付款项 | 396,224,327.11 | 195,881,971.73 | 443,505,620.17 | 697,759,039.64 |
| 其他应收款合计 | 6,775,524.22 | 6,574,451.28 | 16,592,208.3 | 12,494,164.69 |
| 存货 | 1,740,525,848.9 | 1,776,151,615.01 | 1,623,331,283.05 | 1,484,045,023.6 |
| 其他流动资产 | 19,260,582.97 | 36,816,099.73 | 36,046,302.41 | 35,833,803.55 |
| 流动资产合计 | 6,531,692,348.03 | 6,112,848,808.72 | 5,752,197,720.14 | 5,987,061,299.82 |
| 非流动资产: | | | | |
| 长期股权投资 | 96,950,355.92 | 98,707,996.63 | 95,806,310.18 | 98,544,246.69 |
| 其他非流动金融资产 | 20,000,000 | 20,000,000 | 20,000,000 | 20,000,000 |
| 投资性房地产 | 66,715,048.59 | 67,691,366.37 | 68,667,684.15 | 69,644,001.93 |
| 固定资产 | 3,904,402,718.46 | 4,006,121,443.13 | 3,960,696,003.56 | 3,972,211,789.89 |
| 在建工程 | 398,495,698.17 | 282,875,810.07 | 311,580,982.37 | 276,358,673.25 |
| 无形资产 | 341,692,184.37 | 342,650,262.46 | 344,588,660.03 | 346,229,605.7 |
| 商誉 | 25,487.37 | 25,487.37 | 25,487.37 | 25,487.37 |
| 长期待摊费用 | 6,861,292.04 | 6,978,789.47 | 7,096,286.9 | 7,213,784.33 |
| 递延所得税资产 | 13,592,934.13 | 13,518,190.43 | 10,801,239.23 | 12,529,946.78 |
| 其他非流动资产 | 15,366,868.5 | 33,217,513.3 | 7,922,465.04 | 18,273,797.46 |
| 非流动资产合计 | 4,864,102,587.55 | 4,871,786,859.23 | 4,827,185,118.83 | 4,821,031,333.4 |
| 资产总计 | 11,395,794,935.58 | 10,984,635,667.95 | 10,579,382,838.97 | 10,808,092,633.22 |
| 流动负债: | | | | |
| 短期借款 | 511,071,192.22 | 506,101,061.66 | 441,420,885 | 438,662,232 |
| 应付票据及应付账款 | 1,466,102,594.29 | 1,196,294,764.16 | 1,118,191,937.65 | 1,506,066,801.55 |
| 其中：应付票据 | 929,807,230.53 | 661,131,748.42 | 625,331,919.37 | 1,025,218,115.93 |
| 应付账款 | 536,295,363.76 | 535,163,015.74 | 492,860,018.28 | 480,848,685.62 |
| 合同负债 | 43,785,071.3 | 25,348,093.15 | 32,870,800.77 | 38,888,166.54 |
| 应付职工薪酬 | 62,030,317.27 | 107,023,668.18 | 77,516,367.91 | 90,779,039.56 |
| 应交税费 | 52,095,976.96 | 47,275,180.12 | 49,925,840.5 | 47,118,063.67 |
| 其他应付款合计 | 33,056,260.23 | 30,388,978.13 | 36,159,695.21 | 44,191,314.75 |
| 应付股利 | - | - | 621,951.39 | 621,951.39 |
| 一年内到期的非流动负债 | 400,320,000 | 7,293,215.43 | 37,980,000 | 40,328,445.54 |
| 其他流动负债 | 2,629,997.5 | 1,537,372.92 | 2,012,252.6 | 2,688,377.04 |
| 流动负债合计 | 2,571,091,409.77 | 1,921,262,333.75 | 1,796,077,779.64 | 2,208,722,440.65 |
| 非流动负债: | | | | |
| 长期借款 | 82,883,009.06 | 478,011,135.02 | 478,713,635 | 507,001,135.02 |
| 递延收益 | 25,047,103.49 | 25,861,661.5 | 23,443,243.6 | 24,397,606.98 |
| 递延所得税负债 | 1,088,259.63 | 3,944,017.61 | 5,872,816.14 | 6,590,000.88 |
| 非流动负债合计 | 109,018,372.18 | 507,816,814.13 | 508,029,694.74 | 537,988,742.88 |
| 负债合计 | 2,680,109,781.95 | 2,429,079,147.88 | 2,304,107,474.38 | 2,746,711,183.53 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 558,823,500 | 558,823,500 | 558,823,500 | 558,823,500 |
| 资本公积 | 3,627,434,958.46 | 3,627,434,958.46 | 3,607,669,769.18 | 3,607,669,769.18 |
| 减:库存股 | - | - | 111,130,875.89 | 111,130,875.89 |
| 盈余公积 | 241,311,960.71 | 241,311,960.71 | 212,760,772.14 | 212,760,772.14 |
| 未分配利润 | 4,286,182,992.51 | 4,125,553,317.83 | 4,003,526,709.5 | 3,788,853,659.08 |
| 归属于母公司股东权益合计 | 8,713,753,411.68 | 8,553,123,737 | 8,271,649,874.93 | 8,056,976,824.51 |
| 少数股东权益 | 1,931,741.95 | 2,432,783.07 | 3,625,489.66 | 4,404,625.18 |
| 股东权益合计 | 8,715,685,153.63 | 8,555,556,520.07 | 8,275,275,364.59 | 8,061,381,449.69 |
| 负债和股东权益合计 | 11,395,794,935.58 | 10,984,635,667.95 | 10,579,382,838.97 | 10,808,092,633.22 |
| 公告日期 | 2026-04-16 | 2026-03-28 | 2025-10-17 | 2025-07-30 |
| 审计意见(境内) | | 标准无保留意见 | | |